US Senate Criticizes FDA Approval of Vagus Nerve Stimulation
A U.S. Senate Finance Committee report says a federal official approved a device to treat persistent depression against the advice of a scientific advisory committee. According to the Senate committee, the official overruled his scientific staff to approve the vagus nerve stimulator device, despite its not having been proved effective against depression in its only clinical trial.
